Since its foundation in 1929 in Dreux (Eure-et-Loir), Ipsen Laboratoire has embodied French excellence in the pharmaceutical field. This family-run business, now an international player, draws on almost a century of experience to meet patients' healthcare needs. With headquarters in Boulogne-Billancourt (Hauts-de-Seine, France) and strategic research and production sites in France, Ipsen remains firmly rooted in its home territory, while expanding around the world.
Ipsen is recognized for its expertise in three priority therapeutic areas: oncology, rare diseases and neuroscience. These therapeutic areas, often neglected by other players, represent unmet medical needs for millions of patients. The laboratory's ambition is clear: to provide innovative, high-quality treatments that truly transform patients' lives.
At the heart of Ipsen's philosophy is a deep commitment to innovation. The company has developed strategic partnerships with French biotechs, such as GENFIT and AGV Discovery, to foster the development of cutting-edge treatments. Ipsen is also an active investor in the Innobio 1 and 2 funds, which support biomedical research in France.
Ipsen's commitment to innovation is not limited to scientific discoveries. As a founding sponsor of Biolabs, Europe's second-largest innovation cluster located at the Hôtel-Dieu Hospital (AP-HP), Ipsen actively supports biotech startups. This collaboration illustrates the laboratory's objective of contributing to the development of a dynamic and sustainable medical ecosystem.
The Signes (Var) production site is a perfect illustration of Ipsen's quest for excellence. In 2021, this site was awarded the prestigious Shingo d'Or prize, which recognizes operational performance and industrial innovation. Producing nearly 60% of the Group's drugs by value, the Signes site plays a central role in supplying patients, with exports to over 70 countries.
Ipsen's operational excellence is also reflected in rigorous quality control. Each drug is carefully formulated to strict standards to guarantee product safety and efficacy. This reflects a simple philosophy: to provide patients with treatments they can rely on, whatever their health conditions.
Ipsen doesn't just produce medicines; the company is actively committed to a sustainable future. Its sustainability strategy is based on four pillars: the environment, patients, employees and governance. In environmental matters, Ipsen applies international standards such as ISO 14001-2015 to minimize its ecological footprint, and ISO 45001-2018 to guarantee the safety of its employees.
In addition, Ipsen strives to limit the risk of incidents and accidents at its sites, while adopting an ethical approach to business management. These actions reflect a global vision: preserving the planet while improving patients' health and quality of life.
In short, Ipsen is much more than just a pharmaceutical company. With its commitment to innovation, excellence and sustainability, Ipsen is a trusted partner for patients, healthcare professionals and communities.
Ipsen offers a comprehensive range of medicines designed to meet a variety of needs, from gastrointestinal disorders and chronic pain to more complex pathologies. Here is a detailed overview of the brand's flagship products:
These products reflect Ipsen's expertise in digestive, neurological and general health. Each range is developed to offer reliable solutions tailored to patients' specific needs.
Ipsen is constantly evolving to anticipate tomorrow's challenges. Thanks to its investment in research and its collaboration with innovative partners, the company develops targeted treatments that significantly improve patients' lives.
Its commitment to sustainable development is equally remarkable. By implementing initiatives to reduce its carbon footprint, improve resource management and promote the health of communities, Ipsen is resolutely looking to the future.
By choosing Ipsen, you are opting for a laboratory that combines medical expertise, environmental responsibility and social commitment. It's the promise of a company that places patient well-being at the heart of its mission, while working for a more sustainable world.
